InsidersTradesSigma
Track the Avalanche Biotechnologies, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 1 February 2016 (Attribution). Among the most active insiders: Wachter Paul. Every trade is free.
Analysts rate Avalanche Biotechnologies, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Avalanche Biotechnologies, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias génicas para el tratamiento de enfermedades oculares y otras afecciones. Cotiza en el mercado XNAS.